Skip to Content

TEVA 2083 (Hydrochlorothiazide 25 mg)

Pill with imprint TEVA 2083 is Orange, Round and has been identified as Hydrochlorothiazide 25 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide is used in the treatment of high blood pressure; edema; osteoporosis; diabetes insipidus; nephrocalcinosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 2083

Hydrochlorothiazide 25 mg TEVA 2083 Front
Hydrochlorothiazide 25 mg TEVA 2083 Back
Hydrochlorothiazide 25 mg TEVA 2083
Hydrochlorothiazide 25 mg TEVA 2083
Hydrochlorothiazide 25 mg TEVA 2083

Hydrochlorothiazide

Imprint
TEVA 2083
Strength
25 mg
Color
Orange
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Thiazide diuretics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00172-2083

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.